share_log

EXCLUSIVE: Pasithea Therapeutics Acquires Alpha-5 Integrin For Closing Consideration Of 3.26M Shares Of Pasithea Common Stock

EXCLUSIVE: Pasithea Therapeutics Acquires Alpha-5 Integrin For Closing Consideration Of 3.26M Shares Of Pasithea Common Stock

独家:Pasithea治疗公司收购Alpha-5整合素,以结束对326万股Pasithea普通股的对价
Benzinga Real-time News ·  2022/06/22 07:30

EXCLUSIVE: Pasithea Therapeutics Acquires Alpha-5 Integrin For Closing Consideration Of 3.26M Shares Of Pasithea Common Stock

独家:Pasithea治疗公司收购Alpha-5整合素,以结束对326万股Pasithea普通股的对价

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发